U.S. Medical Equipment Stock News

NasdaqGM:GUTS
NasdaqGM:GUTSMedical Equipment

Fractyl Health (GUTS) Is Up 14.0% After RJVA-001 Human Trial Nod And Q1 Profitability Shift – Has The Bull Case Changed?

In May 2026, Fractyl Health reported first-quarter 2026 net income of US$9.22 million, reversing a prior-year loss, and secured authorization in the Netherlands to begin a Phase 1/2 first-in-human trial of RJVA-001, its Smart GLP-1 gene therapy candidate for type 2 diabetes. An important detail for investors is that this regulatory clearance makes Fractyl a dual clinical-stage company, advancing both its Revita procedure for post‑GLP‑1 weight maintenance and its Rejuva gene therapy platform...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Progress Software Award Spotlights Agentic RAG And Undervalued AI Potential

Progress Software (NasdaqGS:PRGS) has received a 2026 Artificial Intelligence Excellence Award for its Agentic RAG platform. The award recognizes the platform in the Retrieval Augmented Generation (RAG) category for its role in AI driven data solutions. Agentic RAG focuses on converting unstructured data into governed intelligence for enterprise use. For you as an investor, this award draws attention to how Progress Software is positioning itself around operational AI rather than only...
NYSE:AMN
NYSE:AMNHealthcare

Is It Time To Reassess AMN Healthcare Services (AMN) After Its Recent Share Price Surge?

If you are wondering whether AMN Healthcare Services at around US$28.61 still offers value, the key question is how its current price compares with what the business may be worth. The stock has been volatile recently, with a slight decline of 1.2% over the past week, a strong 47.7% gain over the past month, 89.2% year to date, yet still down 70.3% over three years and 68.0% over five years. This mix of results can change how investors think about both upside and risk. Recent attention on AMN...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Stronger Q1 Results and Follow-On Offerings Could Be A Game Changer For MGE Energy (MGEE)

In early May 2026, MGE Energy, Inc. reported higher first-quarter revenue of US$242.7 million and net income of US$48.48 million, then completed a US$250.00 million follow-on common stock offering of 3,300,331 shares at US$75.75 each with a US$2.8406 discount per share and filed an additional US$175.00 million follow-on offering. This combination of stronger quarterly earnings and sizable equity capital raises highlights management’s focus on funding future needs through the equity market...
NYSE:VAL
NYSE:VALEnergy Services

Is Valaris (VAL) Trading Profitability for Revenue Stability After Its Narrowed Q1 2026 Loss?

Valaris Limited has reported past first-quarter 2026 results, with revenue of US$465.4 million versus US$620.7 million a year earlier and a net loss of US$16.4 million, compared to US$37.9 million previously. Despite the revenue decline, the company meaningfully narrowed its basic and diluted loss per share from continuing operations to US$0.24, down from US$0.53. We’ll now examine how the reduced net loss, alongside revenue pressure, may influence Valaris’ pre-existing investment narrative...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite DI (CLBT) Profitability Turnaround Tests Bullish Growth Narratives

Cellebrite DI (NasdaqGS:CLBT) opened Q1 2026 with revenue of US$128.3 million and basic EPS of US$0.04, alongside net income of US$10.9 million, with the trailing twelve months showing revenue of US$496.4 million and basic EPS of US$0.29 tied to net income of US$71.4 million. Over recent quarters, revenue has moved from US$107.5 million and basic EPS of US$0.07 in Q1 2025 to around US$128 million and basic EPS in the US$0.08 range through late 2025, then to US$128.3 million and basic EPS of...
NYSE:NIC
NYSE:NICBanks

Is Nicolet Bankshares' (NIC) Revenue Beat Quietly Reframing Its Core Banking Investment Story?

Nicolet Bankshares recently reported quarterly revenue of US$104.4 million, rising 12.4% year on year and exceeding analysts’ estimates, alongside a solid beat on net interest income expectations. The results highlight how stronger-than-expected core banking performance can attract fresh investor attention even when headline earnings already appear broadly healthy. We’ll now examine how this revenue outperformance and net interest income strength may influence Nicolet Bankshares’ broader...
NasdaqGS:GEMI
NasdaqGS:GEMICapital Markets

Assessing Gemini Space Station (GEMI) Valuation After Improved Quarterly Earnings And Ongoing Share Price Weakness

Gemini Space Station (GEMI) is back in focus after reporting first quarter 2026 earnings, with sales of US$48.58 million, revenue of US$50.27 million and a net loss of US$108.98 million, all compared with the prior year period. See our latest analysis for Gemini Space Station. Gemini Space Station’s share price has climbed over the past month, with a 30 day share price return of 15.29% and a 7 day gain of 11.60%. However, year to date the share price return is still down 46.14%, suggesting...